Usana Health Sciences (USNA) Enterprise Value (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Enterprise Value data on file, last reported at -$111.5 million in Q2 2026.

• Enterprise Value for Q2 2026 came in at -$111.5 million, up 11.14% year-over-year; the trailing twelve-month figure through Apr 2026 was -$111.5 million (up 11.14% YoY), and the FY2026 annual result was -$105.2 million, up 17.51% from the prior year.
• Enterprise Value retreated to -$111.5 million in Q2 2026 per USNA's latest filing, from -$105.2 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$91.9 million in Q3 2025 and troughed at -$364.9 million in Q3 2024.
• A 5-year average of -$231.1 million and a median of -$243.4 million in 2022 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2023 and 2025: Enterprise Value plunged 30.3% in 2023, then soared 74.82% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$288.4 million in 2022, then declined by 14.56% to -$330.4 million in 2023, then soared by 61.4% to -$127.5 million in 2024, then gained by 27.97% to -$91.9 million in 2025, then slipped by 21.38% to -$111.5 million in 2026.
• Business Quant data shows USNA's Enterprise Value at -$111.5 million in Q2 2026, -$105.2 million in Q1 2026, and -$91.9 million in Q3 2025.